Myriad Genetics buy Raymond James
Start price
03.03.23
/
50%
€21.85
Target price
03.03.24
€25.45
Performance (%)
-7.55%
End price
04.03.24
€20.20
Summary
This prediction ended on 04.03.24 with a price of €20.20. With a performance of -7.55%, the BUY prediction by Raymond_James finished with a loss. Raymond_James has a follow-up prediction for Myriad Genetics where he still thinks Myriad Genetics is a Buy. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Myriad Genetics | 11.765% | 11.765% | -57.563% | -80.852% |
| iShares Core DAX® | -3.986% | -2.814% | 4.157% | 51.377% |
| iShares Nasdaq 100 | 0.345% | -0.748% | 9.471% | 85.925% |
| iShares Nikkei 225® | -3.853% | 4.229% | 28.358% | 56.859% |
| iShares S&P 500 | 0.298% | 0.379% | 6.139% | 59.567% |
Comments by Raymond_James for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target raised by analysts at Raymond James from $25.00 to $27.00. They now have an "outperform" rating on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten